Kedrion Biopharma is a leading international biopharmaceutical company that specializes in the development, production, and distribution of plasma-derived therapeutics for use in treating rare diseases and conditions such as immune system deficiencies and coagulation disorders. Additionally, Kedrion has a broad range of hyper-immunes, including an anti-rabies HRIG product. Kedrion places a high value on the welfare of those who benefit from its products, as well as on the communities it serves
Brands: KEDRAB